The United States Eventing Association (USEA) would like to welcome back longtime sponsor Adequan® i.m. (polysulfated glycosaminoglycan) as “The Official Joint Therapy Treatment of the USEA”, Title Sponsor of the USEA Gold Cup Series and Contributing Level Sponsor of the USEA American Eventing Championships (AEC). Now in its 14th year, the Gold Cup Series consists of 11 qualifying competitions at the Advanced and CIC3* levels which will culminate at the 2018 USEA American Eventing Championships, August 29-September 2, 2018, at the Colorado Horse Park in Parker, Colorado. The $40,000 Adequan USEA Gold Cup Advanced division serves as the Gold Cup Final at the AEC and the winner of the division will be named the 2018 Adequan USEA Gold Cup Champion.
“Our partnership with the USEA since 2005 continues to be one of our core relationships,” states Allyn Mann, Director of Strategic Partnerships at Luitpold Animal Health. “The Adequan Gold Cup Series and Championship is an important component of our sponsorship. The sport of eventing requires so much and this is one way we can give back to this wonderful community.”
“Year in and year out Adequan steps up to support the sport of eventing in the U.S.,” said USEA CEO Rob Burk. “We are very thankful to be partnered with the company that produces the only product approved by the FDA for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. Eventers care about the health and wellbeing of our equine partners which is why many of our top horses are active in the sport well into their later years.”
About Adequan® i.m. (polysulfated glycosaminoglycan)
Adequan® i.m. is indicated for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. Luitpold Pharmaceuticals, manufacturer of Adequan® invites you to learn more about their products by visiting their website.
About the United States Eventing Association
The USEA is a non-profit 501 C (3), educational organization committed to providing eventing enthusiasts with a competitive level suited to their individual skills. By assisting and educating competitors, event organizers and officials; maintaining responsible safety standards; and registering qualified competitions and clinics, the USEA offers a strong and continuous training opportunity for an ever-expanding field of world-class competitors. Just as importantly, the USEA provides a means for all riders, regardless of age or ability, to experience the thrill of eventing. Learn more about the USEA by visiting the website.
Brand of Polysulfated Glycosaminoglycan (PSGAG)
Adequan® i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
The Fair Hill Organizing Committee (FHOC), an affiliate of the Sport and Entertainment Corporation of Maryland (The Sport Corp.), today announced athletes and horses in the inaugural Maryland 5 Star at Fair Hill (CCI5*-L) will be competing for $300,000 in prize money. Additionally, the US Equestrian Federation (USEF) Eventing National Championship (CCI3*-L), running in conjunction with the 5 Star, will award $25,000 in prize money. Both events, as well as the United States Eventing Association (USEA) Young Event Horse East Coast Championships, will take place this October 14-17 at the new Fair Hill Special Event Zone in Cecil County, Maryland.
You’ve seen a horse you like. You’ve ridden it; you love it. The money’s right; you’ve agreed to buy it. What happens next?
Pre-purchase veterinary examinations are one of those topics that a roomful of horsey people could discuss - and argue amongst themselves about - for hours. For the amateur rider, that can be confusing and slightly alarming.
So, let’s simplify it. What is a pre-purchase examination, why are they done, and what should you expect?
The USEA Intercollegiate Eventing Championships will take place later this month at the Virginia Horse Trials (VHT) in Lexington, Va. across May 27-30. Following the USEF COVID-19 Action Plan, the USEA is working with VHT organizer Andy Bowles to ensure the Championships are still a destination competition for all Intercollegiate event riders, packed full with an opening ceremony, the traditional “college town” area, the prestigious spirit award, and an abundance of prizes.
The FEI passed rule changes impacting Minimum Eligibility Requirements in November 2020 that go into effect on July 1, 2021. The changes will impact athletes who are uncategorized, “D” and “C” athletes competing at the CCI4*-S, CCI3*-L, CCI4*-L, and CCI5*-L levels. Please see below for the highlighted changes. The USEF requirements to compete at these levels remain unchanged, but please remember that the USEF requirements must be achieved within 12 months of the competition. These changes will be adopted into the USEF Eventing Rulebook by July 1. See Appendix 3 for qualification requirements.